Oct 17, 2022 | Press Releases
SARASOTA, Fla. and ANAHEIM, Calif., Oct. 17, 2022 — INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment...
Sep 22, 2022 | Press Releases
SARASOTA, Fla. and ATLANTA, Sept. 22, 2022 — INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell ® medical device and the intravaginal culture...
Aug 25, 2022 | Press Releases
SARASOTA, Fla., Aug. 25, 2022 — INVO Bioscience, Inc. (Nasdaq: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell ® medical device and the intravaginal culture (“IVC”)...
Aug 15, 2022 | Press Releases
Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., Aug. 15, 2022 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company focused on expanding access to advanced treatment...
Aug 4, 2022 | Press Releases
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla., Aug. 4, 2022 — INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment...
Jul 7, 2022 | Press Releases
Mark Your Calendars for July 7, 2022, with Dr. Sue Ellen Carpenter of Atlanta-based Bloom Fertility SARASOTA, Fla., July 7, 2022 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company...
